The EU-Japan Centre for Industrial Cooperation is currently accepting applications to the call for…
9-11 April 2025, Tokyo, Japan
The Trade Promotion Section of the Italian Embassy in Japan will coordinate the participation of 19 leading Italian pharmaceutical companies at CPhI Japan 2025, the premier event for pharmaceutical ingredients and contract services. The exhibition will take place at Tokyo Big Sight (East Hall 6, Booth IP-01 - IP-20). Italy has long been recognized as a key global supplier of active pharmaceutical ingredients (APIs). This leadership stems from the country’s strong chemical industry, world-renowned pharmaceutical companies, cutting-edge manufacturing technology, and top-tier academic institutions that foster innovation and excellence. The Italian Pavilion, spanning 200 square meters, will showcase a diverse array of companies specializing in APIs, contract manufacturing, pharmaceutical equipment, and biotechnology. Among the 19 exhibitors are major industry players such as: Amsa Cosma Clarochem; Anemocyte; Bram-Cor; Chemi; Dipharma Francis; Farmabios - Part of Axplora; Flamma; IBSA; Indena; Laboratori Alchemia; Nerpharma; Newchem; Trifarma. CPhI Japan represents a crucial opportunity for Italian pharmaceutical companies to expand their footprint in Asia, fostering new partnerships and collaborations in one of the world’s most dynamic pharmaceutical markets.
Source: Trade Promotion Section, Embassy of Italy - Tokyo
(Picture shows the Italian Delegation at CPHI 2024)
Published: March 2025
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
